Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma
Background The aim of this research was to evaluate clinical and low-cost genetic determinants of treatment outcome in EGFR mutation positive advanced lung adenocarcinoma patients. Material and Methods EGFR mutation testing and EGFR 181946C>T genotyping were performed in 101 advanced lung adenoca...
Main Authors: | Vera Jokic, Katarina Savic-Vujovic, Jelena Spasic, Zoran Bukumiric, Mladen Marinkovic, Davorin Radosavljevic, Milena Cavic |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-08-01
|
Series: | Dose-Response |
Online Access: | https://doi.org/10.1177/15593258221117354 |
Similar Items
-
Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
by: Neda Nikolic, et al.
Published: (2021-10-01) -
The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas.
by: Jaeyoung Cho, et al.
Published: (2016-01-01) -
Hyoid Bone and Thyroid Cartilage Metastases from Sigmoid Colon Adenocarcinoma: A Case Report
by: Djurdja Bracanovic, et al.
Published: (2017-06-01) -
EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia
by: Miodrag Vukovic, et al.
Published: (2023-11-01) -
The relationship between EGFR mutation and metastasis pattern in lung adenocarcinoma
by: Ismail Beypinar, et al.
Published: (2019-08-01)